JP2013509443A5 - - Google Patents

Download PDF

Info

Publication number
JP2013509443A5
JP2013509443A5 JP2012537169A JP2012537169A JP2013509443A5 JP 2013509443 A5 JP2013509443 A5 JP 2013509443A5 JP 2012537169 A JP2012537169 A JP 2012537169A JP 2012537169 A JP2012537169 A JP 2012537169A JP 2013509443 A5 JP2013509443 A5 JP 2013509443A5
Authority
JP
Japan
Prior art keywords
zinc
dosage form
oral dosage
potassium bicarbonate
amount greater
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012537169A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013509443A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/054981 external-priority patent/WO2011053917A2/en
Publication of JP2013509443A publication Critical patent/JP2013509443A/ja
Publication of JP2013509443A5 publication Critical patent/JP2013509443A5/ja
Pending legal-status Critical Current

Links

JP2012537169A 2009-11-01 2010-11-01 胃保持性の経口用高用量亜鉛調製物 Pending JP2013509443A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25703409P 2009-11-01 2009-11-01
US61/257,034 2009-11-01
PCT/US2010/054981 WO2011053917A2 (en) 2009-11-01 2010-11-01 Gastroretentive oral high dose zinc preparations

Publications (2)

Publication Number Publication Date
JP2013509443A JP2013509443A (ja) 2013-03-14
JP2013509443A5 true JP2013509443A5 (enExample) 2013-12-19

Family

ID=43923047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012537169A Pending JP2013509443A (ja) 2009-11-01 2010-11-01 胃保持性の経口用高用量亜鉛調製物

Country Status (6)

Country Link
US (2) US20110212189A1 (enExample)
EP (1) EP2493484A4 (enExample)
JP (1) JP2013509443A (enExample)
AU (1) AU2010313216A1 (enExample)
CA (1) CA2779518A1 (enExample)
WO (1) WO2011053917A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6716464B2 (ja) * 2014-12-03 2020-07-01 ノーベルファーマ株式会社 酢酸亜鉛水和物錠及びその製造方法
WO2017192818A1 (en) * 2016-05-06 2017-11-09 Physician's Seal, LLC Floating zinc gastric delivery compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3105792A (en) * 1960-11-29 1963-10-01 Warner Lambert Pharmaceutical Stable effervescent compositions and method of preparing same
SE393532B (sv) * 1974-05-02 1977-05-16 Draco Ab Sett att framstella en farmaceutisk zinkberedning for astadkommande av en smaklig, fordragbar, peroral zinklosning innehallande ett zinkkomplex
US4725427A (en) * 1984-03-13 1988-02-16 Albion International, Inc. Effervescent vitamin-mineral granule preparation
US5084482A (en) * 1990-04-10 1992-01-28 The Lithox Corporation Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds
HU217125B (hu) * 1993-03-10 1999-11-29 Béres Rt. Cukor- és nátriummentes pezsgőtabletta és -granulátum és eljárás azok előállítására
US6660297B2 (en) * 2001-03-23 2003-12-09 Bausch & Lomb Incorporated Nutritional supplement to treat macular degeneration
FR2884420B1 (fr) * 2005-04-13 2007-07-06 Labcatal Sa Nouvelle utilisation du gluconate de lithium pour le traitement de l'hidradenite suppuree
JP2009523175A (ja) * 2006-01-10 2009-06-18 パイペックス，インコーポレイテッド 目標とされる安定な銅状態を達成及び維持して銅関連中枢神経系疾患を予防及び治療するための医薬組成物及び方法
ES2562059T3 (es) * 2006-01-27 2016-03-02 Yale University Inhibidor de acción rápida de la secreción de ácido gástrico
ITMI20061522A1 (it) * 2006-08-01 2008-02-02 Difass S A Composizione ad attivita' antiossidante ed antiglicante migliorata
ZA200903854B (en) * 2008-06-19 2011-02-23 Univ Of The Witwatesrand Johannesburg A gastroretentive pharmaceutical dosage form

Similar Documents

Publication Publication Date Title
JP2011522896A5 (enExample)
PT2361081T (pt) Forma de dosagem intra-oral multiporção e seu uso
IL218598A0 (en) Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
ZA201206666B (en) Oral care composition
JP2012524711A5 (enExample)
HUE043175T2 (hu) Szintetikus triterpenoidok és alkalmazásuk betegség kezelésében
PL2519215T3 (pl) Kompozycja do higieny jamy ustnej
PL2538930T3 (pl) Preparaty do doustnego dostarczania środków adsorbujących do jelita
HUE037088T2 (hu) Amiszulpirid ópiát-okozta hányinger és hányás terápiájában való alkalmazásra
IL208879A0 (en) Oral care composition comprising dissolved tin and fluoride
EP2474522A4 (en) AGOME ELITE AND PHARMACEUTICAL COMPOSITIONS THEREOF
JP2014530840A5 (enExample)
SMT202000063T1 (it) Composizione farmaceutica comprendente drospirenone e kit contraccettivo
IL214244A0 (en) Scriptaid isosteres and their use in therapy
PL2285450T3 (pl) Kompozycje do higieny jamy ustnej i sposoby
EP3062377A4 (en) REDOX FLOW BATTERY AND POWER SUPPLY EXHAUST PLATE FOR THE REDOX FLOW BATTERY
DK2131806T3 (da) Mundplejesammensætning omfattende partikulært zinkoxid
ZA201107019B (en) Menthol-derivative compounds and use thereof as oral and systemic active agents
IL226373A (en) Pharmaceutical preparation containing citrate and bicarbonate salts and its use in the treatment of urinary cystine
ZA201304051B (en) Oral and personal care compositions comprising zinc containing films
GB2460178B (en) Depsipeptides and their therapeutic use
GB2460181B (en) Depsipeptides and their therapeutic use
GB0919889D0 (en) Drug composition and its use in therapy
HUP1000407A2 (en) Ph dependent pulsatile and sustained release pharmaceutical composition
GB0908873D0 (en) Depsipeptides and their therapeutic use